Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Doxorubicin in Hormone Refractory Prostate Cancer
NCT00004014Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Apr 1999
- Primary completion
- Jan 2000
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in prostate cancer (PCa), sponsored by Case Comprehensive Cancer Center. Started Apr 1999; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004014.